GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (OTCPK:TWAPF) » Definitions » Price-to-Owner-Earnings

TOWA Pharmaceutical Co (TOWA Pharmaceutical Co) Price-to-Owner-Earnings : (As of Jun. 12, 2024)


View and export this data going back to 2017. Start your Free Trial

What is TOWA Pharmaceutical Co Price-to-Owner-Earnings?

As of today (2024-06-12), TOWA Pharmaceutical Co's share price is $24.35. TOWA Pharmaceutical Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for TOWA Pharmaceutical Co's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of TOWA Pharmaceutical Co was 93.51. The lowest was 13.61. And the median was 41.40.


TWAPF's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 25.08
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-12), TOWA Pharmaceutical Co's share price is $24.35. TOWA Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $2.26. Therefore, TOWA Pharmaceutical Co's PE Ratio for today is 10.77.

As of today (2024-06-12), TOWA Pharmaceutical Co's share price is $24.35. TOWA Pharmaceutical Co's EPS without NRI for the trailing twelve months (TTM) ended in was $1.75. Therefore, TOWA Pharmaceutical Co's PE Ratio without NRI for today is 13.93.

During the past 13 years, TOWA Pharmaceutical Co's highest PE Ratio without NRI was 24.15. The lowest was 7.09. And the median was 12.20.


TOWA Pharmaceutical Co Price-to-Owner-Earnings Historical Data

The historical data trend for TOWA Pharmaceutical Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOWA Pharmaceutical Co Price-to-Owner-Earnings Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

TOWA Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of TOWA Pharmaceutical Co's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TOWA Pharmaceutical Co's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where TOWA Pharmaceutical Co's Price-to-Owner-Earnings falls into.



TOWA Pharmaceutical Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

TOWA Pharmaceutical Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=24.35/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TOWA Pharmaceutical Co  (OTCPK:TWAPF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


TOWA Pharmaceutical Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


TOWA Pharmaceutical Co (TOWA Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co (TOWA Pharmaceutical Co) Headlines

No Headlines